You are here: Home Our Approach Research Projects StemBANCC Project

StemBANCC Project

University of Oxford is the academic lead institution for StemBANCC. This 5 year research programme involves academic and industry partners across 11 countries. Its objective is to develop human-induced pluripotent stem cells as a platform for drug discovery.

New Stembancc logo

This ambitious project brings together internationally renowned scientists and clinicians to study and develop new therapies for 8 major diseases of our time: Alzheimer’s, Parkinson’s, Autism, Schizophrenia, Bipolar, Migraine, Pain and Diabetes.

StemBANCC in Oxford is a grouping of 8 Departments and the world-leading MRC FGU and FMRIB. With our European academic and industry partners, we will create a world-class research programme to develop an unparalleled resource of induced pluripotent stem cells from patients with well characterized disorders; to overcome current bottlenecks in stem cell re-programming and differentiation; to identify molecular and cellular phenotypes of disease in stem cell models; and to translate findings into novel drug screening efficacy and toxicity assays.

We have our kick-off meeting later in 2012 in Basel, Switzerland, where all 25 academic partners, 11 industry partners and the scientific advisory board will convene.

More information will be available soon on the main StemBANCC website.

Project website (Oxford)

HeLEX tag cloud

New post available at HeLEX
HeLEX is recruiting for a Quantitative Researcher to design, execute, analyse and publish survey findings in a number of key areas around the research that HeLEX carries out. The post is offered full-time for a fixed-term of 2 years at Grade 7. Closing date for applications is 12 noon on Monday, 2nd March 2015. More information is available on the Oxford University recruitment website.

Implications of the new EU Data Protection Regulations for Medical Research

Other News